Picture of IDEXX Laboratories logo

IDXX IDEXX Laboratories Share Price

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Momentum

Relative Strength (%)
1m+6.72%
3m+22.02%
6m+18.25%
1yr-19%
Volume Change (%)
10d/3m-21.49%
Price vs... (%)
52w High-34.51%
50d MA+17.33%
200d MA+7.39%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)46.86
PEG Ratio (f)3.46
EPS Growth (f)15.69%
Dividend Yield (f)n/a
Valuation (ttm)IndustryMarket
Price to Book Value75.74
Price to Tang. Book1,738.28
Price to Free Cashflow82.28
Price to Sales10.79
EV to EBITDA38.02

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital60.09%
Return on Equity108.82%
Operating Margin26.09%

Financial Summary

Year End 31st DecUnit201720182019202020212022E2023ECAGR / Avg
Total Revenue$m1,969.062,213.242,406.912,706.663,215.363,352.213,591.5212.61%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%+34.42+31.23+13.37+37.82+29.08-8.26+17.86n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202231st Dec 2023
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2022 / 2023

Blurred out image of IDEXX Laboratories EPS forecast chart

Profile Summary

IDEXX Laboratories, Inc. develops, manufactures and distributes products and provides services for the companion animal veterinary, livestock and poultry, dairy and water testing markets. It also offers human medical point-of-care & laboratory diagnostics. Its products include health monitoring, others. Its segments include Companion Animal Group (CAG), Water quality products (Water), and Livestock, Poultry and Dairy (LPD). The CAG segment CAG develops, designs, manufactures, and distributes products and performs services for veterinarians and the biomedical analytics market, primarily related to diagnostics and information management. The Water segment develops, designs, manufactures, and distributes a range of products used in the detection of various microbiological parameters in water. The LPD segment develops, designs, manufactures, and distributes diagnostic tests and related instrumentation and performs services that are used to manage the health status of livestock and poultry.

Directors

Last Annual
December 31st, 2021
Last Interim
September 30th, 2022
Incorporated
December 19th, 1983
Public Since
June 21st, 1991
No. of Shareholders
390
No. of Employees
10,350
Sector
Healthcare Equipment & Supplies
Industry
Healthcare
Exchange
us flag iconNASDAQ Global Select Market
Shares in Issue
82,816,957
Blurred out image of a map
Address
One Idexx Drive, WESTBROOK, 04092-2041
Web
https://www.idexx.com/
Phone
+1 2075560300
Auditors
PricewaterhouseCoopers LLP

IDXX Share Price Performance

Upcoming Events for IDXX

Q4 2022 IDEXX Laboratories Inc Earnings Release

Q1 2023 IDEXX Laboratories Inc Earnings Release

IDEXX Laboratories Inc Annual Shareholders Meeting

Similar to IDXX

Picture of 10X Genomics logo

10X Genomics

us flag iconNASDAQ Global Select Market

Picture of Abiomed logo

Abiomed

us flag iconNASDAQ Global Select Market

Picture of Accuray logo

Accuray

us flag iconNASDAQ Global Select Market

Picture of Acutus Medical logo

Acutus Medical

us flag iconNASDAQ Global Select Market

Picture of Akoya Biosciences logo

Akoya Biosciences

us flag iconNASDAQ Global Select Market

FAQ

Or unlock with your email

Or unlock with your email